Releases: aritronath/ENDORSE
Releases · aritronath/ENDORSE
ENDORSE biomarker model
ENDORSE model for endocrine resistance prediction in estrogen receptor-positive (ER+) breast cancer.
ENDORSE model for endocrine resistance prediction in estrogen receptor-positive (ER+) breast cancer.